Behavioral Intervention for Youth to Promote Vaping Cessation

Launched by MASSACHUSETTS GENERAL HOSPITAL · Jan 3, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at a program called QuitVaping (QV) to help teenagers stop vaping. Researchers want to see if this program, along with extra texting support, will help young people quit using nicotine more effectively than the usual advice and resources they typically receive. About 400 teens aged 14 to 18 who vape regularly will be involved in the study. They will be randomly divided into two groups: one group will receive the QuitVaping program with texting support, while the other group will get standard care, which includes education about vaping and resources to help them quit.

To participate, teens must have been vaping at least once a week for the past three months and be willing to try quitting in the next 30 days. They should not have used any smoking cessation medications recently, and they need permission from a parent or guardian if they are under 18. Participants can expect to receive support and resources to help them quit, and they will be asked to provide some saliva samples to check for nicotine use. The study is not yet recruiting, but it aims to provide valuable information on effective ways to help teens overcome nicotine dependence.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 14-18 inclusive
• • Self-report of at least weekly nicotine vaping for the prior ≥3 months and semiquantitative saliva screening for cotinine positive for recent nicotine use
• • Self-report of no regular combusted tobacco use (5 consecutive days of smoked tobacco use) in the 2 months prior to enrollment and exhaled CO \<10 ppm
• • Report willingness to try to quit vaping in the next 30 days
• • Able to understand study procedures and read and write in English or Spanish
• • Have a parent or legal guardian who is able and willing to provide written informed consent (if under age 18)
• • Competent and willing to provide written informed consent (if age 18) or assent (if under 18)
• Exclusion Criteria:
• • Use of a smoking cessation medication in the prior month (nicotine patch, gum, nasal spray, or inhaler, varenicline, bupropion)
• • Unwilling to abstain during the study from using smoking cessation aids other than those provided by the study
• • Unwilling to provide saliva or urine samples
• • Any condition or situation that would, in the investigator's opinion, make it unlikely that the participant could adhere safely to the study protocol